Osaterone (developmental code name TZP-5258), also known as 17α-hydroxy-6-chloro-2-oxa-6-dehydroprogesterone, as well as 2-oxachloromadinone, is a steroidal antiandrogen and progestin that was never marketed.[1][2] The C17α acetate ester of osaterone, osaterone acetate, in contrast, has been marketed.[1][2]
Clinical data | |
---|---|
Other names | TZP-5258; Gestoxarone; 2-Oxachloromadinone; 17α-Hydroxy-6-chloro-2-oxa-6-dehydroprogesterone; 17α-Hydroxy-6-chloro-2-oxapregna-4,6-diene-3,20-dione |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H25ClO4 |
Molar mass | 364.87 g·mol−1 |
3D model (JSmol) | |
| |
|
See also
editReferences
edit- ^ a b Index Nominum: International Drug Directory. MedPharm. 2011. ISBN 978-3-8047-5053-1.
- ^ a b Milne GW (8 May 2018). Drugs: Synonyms and Properties: Synonyms and Properties. Taylor & Francis. pp. 969–. ISBN 978-1-351-78989-9.